FEDERICO, Mario
 Distribuzione geografica
Continente #
NA - Nord America 1.011
EU - Europa 684
AS - Asia 181
AF - Africa 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.890
Nazione #
US - Stati Uniti d'America 1.010
FI - Finlandia 186
IT - Italia 149
CN - Cina 135
UA - Ucraina 110
DE - Germania 93
IE - Irlanda 37
SE - Svezia 32
GB - Regno Unito 21
FR - Francia 16
RU - Federazione Russa 15
SG - Singapore 14
BE - Belgio 13
IN - India 9
KR - Corea 8
RO - Romania 8
CI - Costa d'Avorio 5
HK - Hong Kong 5
IR - Iran 4
EU - Europa 3
CO - Colombia 2
GR - Grecia 2
KZ - Kazakistan 2
PE - Perù 2
AR - Argentina 1
CA - Canada 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
LB - Libano 1
MY - Malesia 1
NL - Olanda 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.890
Città #
Ann Arbor 134
Chandler 132
Ashburn 97
Woodbridge 90
Fairfield 65
Jacksonville 56
Wilmington 56
Seattle 38
Dublin 37
Houston 32
Medford 30
Nanjing 27
Beijing 22
Des Moines 22
Altamura 20
Princeton 18
Dearborn 17
Palermo 17
Cambridge 16
Brussels 13
Tulsa 13
Boardman 11
Lawrence 11
Ludwigshafen am Rhein 11
Hebei 9
Jinan 9
Ningbo 9
Shenyang 9
Cagliari 8
Kumar 8
Nanchang 8
New York 8
San Diego 8
Bremen 7
Seongnam 7
Singapore 7
Berlin 6
Changsha 6
Tianjin 6
Abidjan 5
Central 5
Jiaxing 5
Venice 5
Verona 5
San Mateo 4
Auburn Hills 3
Fuzhou 3
Hangzhou 3
Helsinki 3
Milan 3
Taiyuan 3
Taizhou 3
Zhengzhou 3
Andover 2
Aragona 2
Chiclayo 2
Corato 2
Guangzhou 2
Haikou 2
Lanzhou 2
Napoli 2
Rubano 2
Sacramento 2
San Giovanni La Punta 2
San Paolo di Civitate 2
Tehran 2
Almaty 1
Coventry 1
Dallas 1
Den Haag 1
Draveil 1
Düsseldorf 1
Edinburgh 1
Florida 1
Gallipoli 1
Hefei 1
Izmir 1
Kiev 1
Kilburn 1
Kitzingen 1
Kota Kinabalu 1
London 1
Los Angeles 1
Mazara Del Vallo 1
Ottawa 1
Phoenix 1
Pune 1
Quartucciu 1
Saint Petersburg 1
San Jose 1
Sandston 1
Springfield 1
Stepnogorsk 1
Walnut 1
Wandsworth 1
Washington 1
Wuhan 1
Wytheville 1
Zhoushan 1
Totale 1.212
Nome #
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 154
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 153
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 153
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 148
Antiemetic prophylaxis containing Palonosetron (P) alone or in combination with Aprepitant (A) in the treatment of advanced soft tissue sarcoma (STS) patients with epirubicin and ifosfamide 144
Splenic marginal zone lymphoma: a prognostic model for clinical use. 127
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 120
Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial. 107
Radiochemioterapia neoadiuvante nel carcinoma del retto localmente avanzato 101
Carcinoma ereditario dell'ovaio (Ereditary Ovarian Cancer) 94
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 93
A literature-based meta-analysis of the comparison between Gemcitabine-based combination and monochemotherapy for the treatment of advanced non-small cell lung cancer in elderly patients 91
Low dose splenic irradiation in myelofibrosis: outcomes and toxicity of three radiation schedule 91
Early stage nasal vestibule tumors: safety and efficacy of HDR brachyterapy in elderly patients 81
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 80
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 74
R-RESCOVITINE ( SELICICLIB ) INHIBITS DNA DAMAGE-INDUCED CYCLIN A! UP-REGOLATION AND HINDERS NON-HOMOLOGOUS END JOINING: A RATIONAL FOR THERAPEUTIC COMBINATIONS WITH DNA DAMAGING AGENTS 61
R-Rescovitine (Seliciclib) inhibits DNA damage-induced Cyclin A1 up-regulation and hinders non-homologous end joining: a rationale for therapeutic combinations with DNA damaging agents. 57
Totale 1.929
Categoria #
all - tutte 6.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020385 48 20 29 35 33 40 37 16 27 28 55 17
2020/2021214 8 21 2 20 21 0 18 10 36 13 31 34
2021/2022230 17 47 1 22 9 6 8 6 23 39 14 38
2022/2023344 51 60 8 50 40 48 15 17 42 3 10 0
2023/2024151 6 19 9 8 12 25 12 40 1 1 0 18
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.929